
News|Slideshows|August 26, 2016
8 Fairly Weighty Obesity Issues
Author(s)Leo Robert
As the prevalence increases, obesity continues to grow as a major health problem. Here are brief summaries of the latest research findings.
Advertisement
Two-thirds of Americans are considered overweight or obese, and as the prevalence increases, obesity continues to grow as a major health problem. Click through the slideshow above for brief summaries of the latest research findings.Additional information on the studies is availabe below.
References:
Advertisement
Related to this article

EASD 2026: The combination of semaglutide/cagrilintide altered food-cue responses and showed a 22.4% estimated weight difference vs placebo; separate data found less organ fat in type 2 diabetes.

FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.

Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.

A new scientific statement calls for a shift in obesity management and treatment to focus on overall health improvements rather than just weight loss alone.

Semaglutide brought 40.4% of children below the obesity BMI threshold, according to top-line results from the phase 3 STEP Young clinical trial.

US clinicians increasingly prescribe GLP-1 drugs to young children with obesity, although overall use remains limited and access disparities persist.

A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
Advertisement
Advertisement
Trending on Patient Care Online
1
Atrial Fibrillation Stroke Prevention: Expert Guidance for Primary Care Physicians
2
5 FDA Decisions for Primary Care to Know from September 2026
3
Lebrikizumab Improves Hand and Foot Atopic Dermatitis in Phase 3b Trial
4
Fezolinetant Linked to 2.6 Fewer Nighttime Awakenings in Women With Menopausal VMS
5
